Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021
JAMA Network Open · 21.06.2023 · 6 (6) · e2319172
DOI: 10.1001/jamanetworkopen.2023.19172 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA Network Open, online erschienen am 21.06.2023. Verfasst von Kristin G Maki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
This cross-sectional study estimates the prevalence of lung cancer screening among eligible adults in 2021 and examines factors associated with screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
- University of Texas MD Anderson Cancer Center, Houston.
Förderung
- NCI NIH HHS
Zitieren
APA
Maki, K. G., Tan, N. Q. P., Toumazis, I., & Volk, R. J. (2023). Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021. JAMA Network Open, 6(6), e2319172. https://doi.org/10.1001/jamanetworkopen.2023.19172
Vancouver
Maki KG, Tan NQP, Toumazis I, Volk RJ. Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021. JAMA Network Open. 2023;6(6):e2319172. doi:10.1001/jamanetworkopen.2023.19172
BibTeX
@article{Maki2023,
author = {Maki, Kristin G and Tan, Naomi Q P and Toumazis, Iakovos and Volk, Robert J},
title = {Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021},
journal = {JAMA Network Open},
year = {2023},
volume = {6},
number = {6},
pages = {e2319172},
doi = {10.1001/jamanetworkopen.2023.19172}
}
EUVIMED